机构:[1]Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Zhejiang Key Laboratory of Alzheimer’s Disease, Zhejiang Provincial Clinical ResearchCenter for Mental Disorders, School of Mental Health and Wenzhou Kangning Hospital, The Second Affiliated Hospital and Yuying Children’s Hospital, Institute of Aging, WenzhouMedical University, Wenzhou, Zhejiang 325035, China[2]Townsend Family Laboratories, Department of Psychiatry, Brain Research Center, The University of British Columbia, 2255Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada[3]Chongqing Key Laboratory of Translational Medical Research in Cognitive Development and Learning and Memory Disorders,Ministry of Education Key Laboratory of Child Development and Disorders, Children’s Hospital of Chongqing Medical University, Chongqing 400014, China[4]Center for MedicalGenetics, Hunan Key Laboratory of Animal Models for Human Diseases, Hunan Key Laboratory of Medical Genetics, Hunan International Scientific and Technological CooperationBase of Animal Models for Human Diseases, School of Life Sciences, Central South University, Changsha 410078 Hunan, China[5]The National Clinical Research Center forGeriatric Disease, Xuanwu Hospital, Capital Medical University, Beijing 100053, China首都医科大学宣武医院
The work was supported by the funding from the Key Laboratory of Alzheimer’s
Disease of Zhejiang Province and Oujiang Laboratory (W.S.) and National Natural
Science Foundation of China: 82301615 (M.X.); Q.Z. was the recipient of UBC Four
Year Doctoral Fellowship and DMCBH Innovation Fund Graduate Trainee Award; M.X.
is the funding recipient from the China Postdoctoral Science Foundation (grant no.
2022M712435). We thank Dr. Laurence Goutebroze for providing us with CNTNAP2
pathogenic mutation plasmids.
第一作者机构:[1]Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Zhejiang Key Laboratory of Alzheimer’s Disease, Zhejiang Provincial Clinical ResearchCenter for Mental Disorders, School of Mental Health and Wenzhou Kangning Hospital, The Second Affiliated Hospital and Yuying Children’s Hospital, Institute of Aging, WenzhouMedical University, Wenzhou, Zhejiang 325035, China[2]Townsend Family Laboratories, Department of Psychiatry, Brain Research Center, The University of British Columbia, 2255Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada
共同第一作者:
通讯作者:
通讯机构:[1]Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Zhejiang Key Laboratory of Alzheimer’s Disease, Zhejiang Provincial Clinical ResearchCenter for Mental Disorders, School of Mental Health and Wenzhou Kangning Hospital, The Second Affiliated Hospital and Yuying Children’s Hospital, Institute of Aging, WenzhouMedical University, Wenzhou, Zhejiang 325035, China[2]Townsend Family Laboratories, Department of Psychiatry, Brain Research Center, The University of British Columbia, 2255Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada[3]Chongqing Key Laboratory of Translational Medical Research in Cognitive Development and Learning and Memory Disorders,Ministry of Education Key Laboratory of Child Development and Disorders, Children’s Hospital of Chongqing Medical University, Chongqing 400014, China[5]The National Clinical Research Center forGeriatric Disease, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
推荐引用方式(GB/T 7714):
Qing Zhang,Mengen Xing,Zhengkai Bao,et al.Contactin-associated protein-like 2 (CNTNAP2) mutations impair the essential α-secretase cleavages, leading to autism-like phenotypes[J].Signal Transduction And Targeted Therapy.2024,9(1):51.doi:10.1038/s41392-024-01768-6.
APA:
Qing Zhang,Mengen Xing,Zhengkai Bao,Lu Xu,Yang Bai...&Weihong Song.(2024).Contactin-associated protein-like 2 (CNTNAP2) mutations impair the essential α-secretase cleavages, leading to autism-like phenotypes.Signal Transduction And Targeted Therapy,9,(1)
MLA:
Qing Zhang,et al."Contactin-associated protein-like 2 (CNTNAP2) mutations impair the essential α-secretase cleavages, leading to autism-like phenotypes".Signal Transduction And Targeted Therapy 9..1(2024):51